Indigo BioSystems Successfully Tests First Globally Accessible CRO Data Integration System

Three dimensional data can now be globally accessible thanks to the CRO Data Integration System that was just successfully implemented today from Indiana, USA to China. This will allow CROs across the world to access pertinent information and make quick decisions regarding the research of pharmaceuticals, etc. Before the implementation of this system, files were too big to send to other research labs, causing much delay for an industry whose survival is now based on being the first to find and release valuable information. How will this effect the world of CROs? We'd like to hear your thoughts.

From MSNBC

India's clinical trials not affected by the recession

Last week, we wrote about the opportunity that the global recession is presenting to India and their clinical trials.

While the cost of clinical trials vary on the basis of complexity and disease segment, a simple trial in India can cost 15-20% of the US price, while a more sophisticated trial—involving imaging systems—may be 50-60% of the US price. Studies suggest that R&D expenditure is increasing by 15% per year, making global biopharmaceutical companies look for cheaper options. India scores high due to faster enrollments, speed of completion, large and diverse patient pool as well as increasing private healthcare network.

The Economic Times takes a deeper look into this belief. Read more here.

Averion expands in Eastern Europe

Averion, a clinical research outsourcer, recently announced that they'd be expanding operations and opening an office in Prague, Czech Republic. This is following a recent opening in Kiev, Ukraine, as well as Russia, Slovakia and Hungary.

According to this article:

The Czech Republic offers a strong clinical trial environment with large patient populations and well-qualified investigators in a broad range of indications, i.e. factors seen by its clients as top priorities and vital to the successful conduct of international trials.

ethica Clinical Research expands to South America

According to Pharma Times, The Canadian Clinical Research outsourcer, ethica, will be expanding operations to Buenos Aires, Argentina. They'll be partnering with Blanchard y Asociados, who is headquartered in Buenos Aires. They'll be expanding their human research protection program in to this section of the world.

Dr. Janice Parente, the founder and president of ethica has this to say about their expansion:

"While clinical research has globalised and nearly half of the world’s clinical trials are now being conducted outside of North America and Western Europe, there is a need to develop a global approach to the oversight of research on humans. We are proud to be playing a pivotal role toward achieving this goal.”